Financhill
Back

Xeris Biopharma Holdings Vs. Zevra Therapeutics Industry Stock Comparison

Buy
74

XERS
Xeris Biopharma Holdings

Last Price:
$3.49
Seasonality Move:
-18.08%
Sell
44

ZVRA
Zevra Therapeutics

Last Price:
$8.49
Seasonality Move:
-0.81%
Buy
74
Xeris Biopharma Holdings (XERS) is a Buy

Is Xeris Biopharma Holdings a Buy, Sell or Hold?

  • The current Xeris Biopharma Holdings [XERS] share price is $3.49. The Score for XERS is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
  • XERS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
44
Zevra Therapeutics (ZVRA) is a Sell

Is Zevra Therapeutics a Buy, Sell or Hold?

  • The current Zevra Therapeutics [ZVRA] share price is $8.49. The Score for ZVRA is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • ZVRA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

XERS Stock Price Chart

What is Xeris Biopharma Holdings's stock price today?

  • The Xeris Biopharma Holdings share price today is $3.49
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XERS is experiencing slight buying pressure.

ZVRA Stock Price Chart

What is Zevra Therapeutics's stock price today?

  • The Zevra Therapeutics share price today is $8.49
    The current trend is relatively stagnant and ZVRA is experiencing slight selling pressure.

XERS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.06 Buy
Relative Strength Index (14 RSI): 55.91 Buy
Chaikin Money Flow: 422045 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.09 - 3.55) Buy
Bollinger Bands (100): (2.64 - 3.32) Buy

ZVRA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 44.11 Sell
Chaikin Money Flow: -999179 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.54 - 9.36) Sell
Bollinger Bands (100): (7.24 - 8.84) Buy

XERS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.39 Buy
20-day SMA: 3.41 Buy
50-day SMA: 3.24 Buy
200-day SMA: 2.55 Buy
8-day EMA: 3.41 Buy
20-day EMA: 3.38 Buy
50-day EMA: 3.24 Buy
200-day EMA: 2.75 Buy

ZVRA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.5 Sell
20-day SMA: 8.98 Sell
50-day SMA: 8.69 Sell
200-day SMA: 6.59 Buy
8-day EMA: 8.56 Sell
20-day EMA: 8.74 Sell
50-day EMA: 8.56 Sell
200-day EMA: 7.14 Buy

Xeris Biopharma Holdings Earnings Growth & XERS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.13 per share, and an increase next year of $0.05 per share.

Zevra Therapeutics Earnings Growth & ZVRA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.75 per share, and an increase next year of $1.62 per share.

Xeris Biopharma Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Zevra Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):